Search

Your search keyword '"Zalunardo, B"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Zalunardo, B" Remove constraint Author: "Zalunardo, B"
95 results on '"Zalunardo, B"'

Search Results

51. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

52. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

53. Platelet count and outcome in patients with acute venous thromboembolism

54. Clinical presentation and outcome of venous thromboembolism in COPD

55. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

56. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

57. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

58. Venous thromboembolism in patients immobilised at home

59. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

60. DVT Management and Outcome Trends, 2001 to 2014

61. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry

62. Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism

63. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer

64. Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function

65. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

66. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

67. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

72. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism

73. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

74. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

75. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

76. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

77. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

78. Timing and characteristics of venous thromboembolism after noncancer surgery

79. Monoethylglycinexylide kinetics and galactose elimination capacity during treatment with interferon-alfa for hepatitis C virus infection: possible predictors of response?

80. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

81. DVT Management and Outcome Trends, 2001 to 2014

82. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

83. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

84. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

86. Acute pulmonary embolism and cancer: findings from the COPE study.

87. Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study.

88. Bleeding Risk in Patients with Peripheral Arterial Disease.

89. Vascular risk assessment and management.

90. Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients' and Clinicians' Awareness.

91. Peripheral artery disease, the 'lost syndrome' during lockdown for COVID-19: A report of three cases.

93. Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism.

94. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.

95. Gallstone disease in an elderly population: the Silea study.

Catalog

Books, media, physical & digital resources